GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Star Lake Bioscience Co Inc (SHSE:600866) » Definitions » Cyclically Adjusted FCF per Share

Star Lake Bioscience Co (SHSE:600866) Cyclically Adjusted FCF per Share : ¥0.17 (As of Mar. 2024)


View and export this data going back to 1994. Start your Free Trial

What is Star Lake Bioscience Co Cyclically Adjusted FCF per Share?

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

Star Lake Bioscience Co's adjusted free cash flow per share for the three months ended in Mar. 2024 was ¥-0.142. Add all the adjusted free cash flow per share for the past 10 years together and divide the count will get our Cyclically Adjusted FCF per Share, which is ¥0.17 for the trailing ten years ended in Mar. 2024.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the Cyclically Adjusted FCF Growth Rate using Cyclically Adjusted FCF per Share data.

During the past 13 years, the highest 3-Year average Cyclically Adjusted FCF Growth Rate of Star Lake Bioscience Co was 15.40% per year. The lowest was -115.40% per year. And the median was -4.90% per year.

As of today (2024-06-09), Star Lake Bioscience Co's current stock price is ¥6.26. Star Lake Bioscience Co's Cyclically Adjusted FCF per Share for the quarter that ended in Mar. 2024 was ¥0.17. Star Lake Bioscience Co's Cyclically Adjusted Price-to-FCF of today is 36.82.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Star Lake Bioscience Co was 230.33. The lowest was 23.94. And the median was 64.75.


Star Lake Bioscience Co Cyclically Adjusted FCF per Share Historical Data

The historical data trend for Star Lake Bioscience Co's Cyclically Adjusted FCF per Share can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Star Lake Bioscience Co Cyclically Adjusted FCF per Share Chart

Star Lake Bioscience Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Cyclically Adjusted FCF per Share
Get a 7-Day Free Trial Premium Member Only Premium Member Only -0.40 -0.33 -0.20 0.03 0.16

Star Lake Bioscience Co Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Cyclically Adjusted FCF per Share Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 0.08 0.15 0.16 0.17

Competitive Comparison of Star Lake Bioscience Co's Cyclically Adjusted FCF per Share

For the Biotechnology subindustry, Star Lake Bioscience Co's Cyclically Adjusted Price-to-FCF, along with its competitors' market caps and Cyclically Adjusted Price-to-FCF data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Star Lake Bioscience Co's Cyclically Adjusted Price-to-FCF Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Star Lake Bioscience Co's Cyclically Adjusted Price-to-FCF distribution charts can be found below:

* The bar in red indicates where Star Lake Bioscience Co's Cyclically Adjusted Price-to-FCF falls into.



Star Lake Bioscience Co Cyclically Adjusted FCF per Share Calculation

E10 is a concept invented by Prof. Robert Shiller, who uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted FCF per Share and the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years.

What is Cyclically Adjusted FCF per Share? How do we calculate Cyclically Adjusted FCF per Share?

Cyclically Adjusted FCF per Share is the average of the inflation adjusted Free Cash Flow per Share of a company over the past 10 years. Let's use an example to explain.

If we want to calculate the Cyclically Adjusted FCF per Share of Wal-Mart (WMT) for Dec. 31, 2010, we need to have the inflation data and the free cash flow per share from 2001 through 2010.

We adjusted the 2001 free cash flow per share data with the total inflation from 2001 through 2010 to the equivalent free cash flow in 2010. If the total inflation from 2001 to 2010 is 40%, and Wal-Mart's free cash flow is $1 a share in 2001, then the 2001's equivalent free cash flow in 2010 is $1.4 a share. If Wal-Mart's free cash flow is $1 again in 2002, and the total inflation from 2002 through 2010 is 35%, then the equivalent 2002 free cash flow in 2010 is $1.35. So on and so forth, you get the equivalent free cash flow per share of past 10 years. Then you add them together and divided the sum by the count to get Cyclically Adjusted FCF per Share.

Please note that we use the CPI data of the country/region where the company is headquartered. If the CPI data for that country/region is not available, then we will use the CPI data of the United States as default.

For example, Star Lake Bioscience Co's adjusted Free Cash Flow per Share data for the three months ended in Mar. 2024 was:

Adj_FreeCashFlowPerShare= Free Cash Flow per Share /CPI of Mar. 2024 (Change)*Current CPI (Mar. 2024)
=-0.142/115.2271*115.2271
=-0.142

Current CPI (Mar. 2024) = 115.2271.

Star Lake Bioscience Co Quarterly Data

Free Cash Flow per Share CPI Adj_FreeCashFlowPerShare
201406 -0.044 98.200 -0.052
201409 0.004 98.900 0.005
201412 0.059 99.000 0.069
201503 -0.005 99.900 -0.006
201506 -0.069 99.500 -0.080
201509 -0.047 100.500 -0.054
201512 -0.035 100.600 -0.040
201603 -0.004 102.200 -0.005
201606 0.043 101.400 0.049
201609 -0.050 102.400 -0.056
201612 0.016 102.600 0.018
201703 -0.029 103.200 -0.032
201706 0.056 103.100 0.063
201709 -0.012 104.100 -0.013
201712 -0.001 104.500 -0.001
201803 -0.005 105.300 -0.005
201806 -0.016 104.900 -0.018
201809 -0.014 106.600 -0.015
201812 0.083 106.500 0.090
201903 0.079 107.700 0.085
201906 0.083 107.700 0.089
201909 -0.031 109.800 -0.033
201912 -0.053 111.200 -0.055
202003 0.001 112.300 0.001
202006 -0.057 110.400 -0.059
202009 -0.093 111.700 -0.096
202012 0.095 111.500 0.098
202103 -0.098 112.662 -0.100
202106 -0.069 111.769 -0.071
202109 0.022 112.215 0.023
202112 -0.073 113.108 -0.074
202203 0.027 114.335 0.027
202206 0.182 114.558 0.183
202209 1.161 115.339 1.160
202212 -0.271 115.116 -0.271
202303 -0.442 115.116 -0.442
202306 0.667 114.558 0.671
202309 0.732 115.339 0.731
202312 0.037 114.781 0.037
202403 -0.142 115.227 -0.142

Add all the adjusted free cash flow per share together and divide 10 will get our Cyclically Adjusted FCF per Share.


Star Lake Bioscience Co  (SHSE:600866) Cyclically Adjusted FCF per Share Explanation

If a company grows much fast than inflation, Cyclically Adjusted FCF per Share may underestimate the company's free cash flow. Cyclically Adjusted Price-to-FCF can seem to be too high even the actual Price-to-Free-Cash-Flow is low.

For the Cyclically Adjusted Price-to-FCF, the free cash flow per share of the past 10 years are inflation-adjusted and averaged. The result is used for P/FCF calculation. Since it looks at the average over the last 10 years, the Cyclically Adjusted Price-to-FCF is also called CAPFCF Ratio.

The Shiller PE Ratio was first used by professor Robert Shiller. He uses E10 for his Shiller PE Ratio calculation. E10 is the average of the inflation adjusted earnings per share of a company over the past 10 years. The similar calculation is applied by GuruFocus to calculate the Cyclically Adjusted Price-to-FCF. The Cyclically Adjusted FCF per Share is the average of the inflation adjusted free cash flow per share of a company over the past 10 years.

Star Lake Bioscience Co's Cyclically Adjusted Price-to-FCF of today is calculated as

Cyclically Adjusted Price-to-FCF=Share Price/Cyclically Adjusted FCF per Share
=6.26/0.17
=36.82

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

During the past 13 years, the highest Cyclically Adjusted Price-to-FCF of Star Lake Bioscience Co was 230.33. The lowest was 23.94. And the median was 64.75.


Be Aware

Cyclically Adjusted Price-to-FCF works better for cyclical companies. It gives you a better idea on the company's real free cash flow value.


Star Lake Bioscience Co Cyclically Adjusted FCF per Share Related Terms

Thank you for viewing the detailed overview of Star Lake Bioscience Co's Cyclically Adjusted FCF per Share provided by GuruFocus.com. Please click on the following links to see related term pages.


Star Lake Bioscience Co (SHSE:600866) Business Description

Traded in Other Exchanges
N/A
Address
No. 67 Gongnong North Road, Guangdong Province, Zhaoqing, CHN, 526060
Star Lake Bioscience Co Inc is a China-based Pharmaceutical manufacturer. The company is mainly engaged in the research, development, production, and sales of chemical raw materials and pharmaceutical intermediates. Products offered by the company include proline, guanosine, adenosine, adenine, adefovir dipivoxil, memantine hydrochloride, Proline, threonine, lysine, among others. Its products are used in food processing, feed processing, and pharmaceutical manufacturing. Star Lake sells its products through direct sales and distributors in China and overseas markets.
Executives
Chen Wu Director
Liu Xian Yi Director
Liao Jie Ming senior management
Chen Chao Ju Director
Li Qing Lin Supervisors
Zhong Zi Rong Director

Star Lake Bioscience Co (SHSE:600866) Headlines

No Headlines